Tech Company Financing Transactions
CaaMTech Funding Round
CaaMTech, based in Issaquah, raised $22 million from Noetic Fund and private investors.
Transaction Overview
Company Name
Announced On
9/10/2021
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series A
Investors
Noetic Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support its cross-disciplinary science program, expand its leadership team, and advance its foremost drug development candidates into human trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
58 East Sunset Way 209
Issaquah, WA 98027
USA
Issaquah, WA 98027
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of modern medicine. CaaMTech is improving the health and happiness of humankind by creating and optimizing psychedelic compounds and formulations through rigorous science and continuous innovation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Chadeayne
Browse more venture capital transactions:
Prev: 9/10/2021: Headout venture capital transaction
Next: 9/13/2021: Nectero Medical venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs